Global ePharmacy - Market

ePharmacy - Comprehensive Study by Type (Skin Care, Dental, Cold and Flu, Vitamins, Weight Loss, Others), Drug Type (Prescription Drugs, Over The Counter (OTC) Drugs) Players and Region - Global Market Outlook to 2027

ePharmacy - Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 15.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
ePharmacy - Market Scope
E pharmacy enables the patients purchase the required pharmaceutical products across the globe with the help online portals. Increasing digitalization across the globe as well as safe and favorable government regulations will lead to boost the E pharmacy or Online Pharmacy Market. Consumers only have to place the orders according to their requirement by online website or mobile application, and the E-pharmacy companies distribute their products at the consumer’s places. E-pharmacy is also referred to as Mail-Order pharmacy and Internet Pharmacy or Online Pharmacy.

According to AMA, the Global ePharmacy - market is expected to see growth rate of 15.8% and may see market size of USD115.6 Billion by 2027.

Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global ePharmacy - market throughout the predicted period.

The Kroger Co. (United States), Walgreen Co. (United States), Walmart Stores, Inc. (United States), CVS Health (United States), Express Scripts Holding Company (United States), Giant Eagle, Inc. (United States), DocMorris (Zur Rose Group) (Switzerland), Rowlands Pharmacy (United States), OptumRx Inc. (United States) and MediSave (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are eDrugstore.MD (United States), The SANICARE Group (Sweden), CanDrugstore.com (Canada), Domzdrowia.pl SA (Poland) and CanadaDrugs.com (Canada).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.

Segmentation Overview
The study have segmented the market of Global ePharmacy - market by Type (Skin Care, Dental, Cold and Flu, Vitamins, Weight Loss and Others) and Region with country level break-up.

On the basis of geography, the market of ePharmacy - has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Leaders and their expansionary development strategies
On October 2nd, 2018, The Kroger Co. and Walgreens has announced that these companies are collaborating on an exploratory pilot with a new format and concept that combines Kroger’s role as America’s grocer and food authority with Walgreens global expertise in pharmacy, health and beauty.

According to United States Food and Drug Administration Cybercrime Investigation Unit, “Individuals who traffic in counterfeit drugs or controlled substances and dispense prescription drugs without a valid prescriptions or otherwise receives and distributes adulterated as well as misbranded drugs are subject to number of penalties under the Federal Law. For Instance; recently in 2018, some Canadian online pharmacy company was importing some illegal cancer drugs which was not being approved by government bod

Market Trend
  • Gaining Popularity owing to Price Discounts
  • Improved Customer-Pharmacist Interaction

Market Drivers
  • Increasing Prevalence of Numerous Diseases across the Globe
  • Constantly Increasing Demand in Emerging Economies
  • Growing Geriatric Population

Opportunities
  • Enhanced Healthcare Infrastructure
  • Introduction to E-Prescriptions
  • Globally Increasing Demand for E medicinal Products

Restraints
  • Rising Instances of Illegal Online Pharmacies
  • Hidden Dues Added to Drug Prices

Challenges
  • Stringent Government Regulations
  • Privacy related to Personal and Financial Information


Key Target Audience
E-pharmacist, Pharma Industry, Healthcare Industry, Government Agencies, Research and Development Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Skin Care
  • Dental
  • Cold and Flu
  • Vitamins
  • Weight Loss
  • Others
By Drug Type
  • Prescription Drugs
  • Over The Counter (OTC) Drugs

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Numerous Diseases across the Globe
      • 3.2.2. Constantly Increasing Demand in Emerging Economies
      • 3.2.3. Growing Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Stringent Government Regulations
      • 3.3.2. Privacy related to Personal and Financial Information
    • 3.4. Market Trends
      • 3.4.1. Gaining Popularity owing to Price Discounts
      • 3.4.2. Improved Customer-Pharmacist Interaction
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global ePharmacy -, by Type, Drug Type and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global ePharmacy - (Value)
      • 5.2.1. Global ePharmacy - by: Type (Value)
        • 5.2.1.1. Skin Care
        • 5.2.1.2. Dental
        • 5.2.1.3. Cold and Flu
        • 5.2.1.4. Vitamins
        • 5.2.1.5. Weight Loss
        • 5.2.1.6. Others
      • 5.2.2. Global ePharmacy - by: Drug Type (Value)
        • 5.2.2.1. Prescription Drugs
        • 5.2.2.2. Over The Counter (OTC) Drugs
      • 5.2.3. Global ePharmacy - Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. ePharmacy -: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. The Kroger Co. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Walgreen Co. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Walmart Stores, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. CVS Health (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Express Scripts Holding Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Giant Eagle, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. DocMorris (Zur Rose Group) (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Rowlands Pharmacy (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. OptumRx Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. MediSave (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global ePharmacy - Sale, by Type, Drug Type and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global ePharmacy - (Value)
      • 7.2.1. Global ePharmacy - by: Type (Value)
        • 7.2.1.1. Skin Care
        • 7.2.1.2. Dental
        • 7.2.1.3. Cold and Flu
        • 7.2.1.4. Vitamins
        • 7.2.1.5. Weight Loss
        • 7.2.1.6. Others
      • 7.2.2. Global ePharmacy - by: Drug Type (Value)
        • 7.2.2.1. Prescription Drugs
        • 7.2.2.2. Over The Counter (OTC) Drugs
      • 7.2.3. Global ePharmacy - Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. ePharmacy -: by Type(USD Billion)
  • Table 2. ePharmacy - Skin Care , by Region USD Billion (2016-2021)
  • Table 3. ePharmacy - Dental , by Region USD Billion (2016-2021)
  • Table 4. ePharmacy - Cold and Flu , by Region USD Billion (2016-2021)
  • Table 5. ePharmacy - Vitamins , by Region USD Billion (2016-2021)
  • Table 6. ePharmacy - Weight Loss , by Region USD Billion (2016-2021)
  • Table 7. ePharmacy - Others , by Region USD Billion (2016-2021)
  • Table 8. ePharmacy -: by Drug Type(USD Billion)
  • Table 9. ePharmacy - Prescription Drugs , by Region USD Billion (2016-2021)
  • Table 10. ePharmacy - Over The Counter (OTC) Drugs , by Region USD Billion (2016-2021)
  • Table 11. South America ePharmacy -, by Country USD Billion (2016-2021)
  • Table 12. South America ePharmacy -, by Type USD Billion (2016-2021)
  • Table 13. South America ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 14. Brazil ePharmacy -, by Type USD Billion (2016-2021)
  • Table 15. Brazil ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 16. Argentina ePharmacy -, by Type USD Billion (2016-2021)
  • Table 17. Argentina ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 18. Rest of South America ePharmacy -, by Type USD Billion (2016-2021)
  • Table 19. Rest of South America ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 20. Asia Pacific ePharmacy -, by Country USD Billion (2016-2021)
  • Table 21. Asia Pacific ePharmacy -, by Type USD Billion (2016-2021)
  • Table 22. Asia Pacific ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 23. China ePharmacy -, by Type USD Billion (2016-2021)
  • Table 24. China ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 25. Japan ePharmacy -, by Type USD Billion (2016-2021)
  • Table 26. Japan ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 27. India ePharmacy -, by Type USD Billion (2016-2021)
  • Table 28. India ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 29. South Korea ePharmacy -, by Type USD Billion (2016-2021)
  • Table 30. South Korea ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 31. Taiwan ePharmacy -, by Type USD Billion (2016-2021)
  • Table 32. Taiwan ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 33. Australia ePharmacy -, by Type USD Billion (2016-2021)
  • Table 34. Australia ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 35. Rest of Asia-Pacific ePharmacy -, by Type USD Billion (2016-2021)
  • Table 36. Rest of Asia-Pacific ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 37. Europe ePharmacy -, by Country USD Billion (2016-2021)
  • Table 38. Europe ePharmacy -, by Type USD Billion (2016-2021)
  • Table 39. Europe ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 40. Germany ePharmacy -, by Type USD Billion (2016-2021)
  • Table 41. Germany ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 42. France ePharmacy -, by Type USD Billion (2016-2021)
  • Table 43. France ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 44. Italy ePharmacy -, by Type USD Billion (2016-2021)
  • Table 45. Italy ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 46. United Kingdom ePharmacy -, by Type USD Billion (2016-2021)
  • Table 47. United Kingdom ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 48. Netherlands ePharmacy -, by Type USD Billion (2016-2021)
  • Table 49. Netherlands ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 50. Rest of Europe ePharmacy -, by Type USD Billion (2016-2021)
  • Table 51. Rest of Europe ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 52. MEA ePharmacy -, by Country USD Billion (2016-2021)
  • Table 53. MEA ePharmacy -, by Type USD Billion (2016-2021)
  • Table 54. MEA ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 55. Middle East ePharmacy -, by Type USD Billion (2016-2021)
  • Table 56. Middle East ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 57. Africa ePharmacy -, by Type USD Billion (2016-2021)
  • Table 58. Africa ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 59. North America ePharmacy -, by Country USD Billion (2016-2021)
  • Table 60. North America ePharmacy -, by Type USD Billion (2016-2021)
  • Table 61. North America ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 62. United States ePharmacy -, by Type USD Billion (2016-2021)
  • Table 63. United States ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 64. Canada ePharmacy -, by Type USD Billion (2016-2021)
  • Table 65. Canada ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 66. Mexico ePharmacy -, by Type USD Billion (2016-2021)
  • Table 67. Mexico ePharmacy -, by Drug Type USD Billion (2016-2021)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. ePharmacy -: by Type(USD Billion)
  • Table 79. ePharmacy - Skin Care , by Region USD Billion (2022-2027)
  • Table 80. ePharmacy - Dental , by Region USD Billion (2022-2027)
  • Table 81. ePharmacy - Cold and Flu , by Region USD Billion (2022-2027)
  • Table 82. ePharmacy - Vitamins , by Region USD Billion (2022-2027)
  • Table 83. ePharmacy - Weight Loss , by Region USD Billion (2022-2027)
  • Table 84. ePharmacy - Others , by Region USD Billion (2022-2027)
  • Table 85. ePharmacy -: by Drug Type(USD Billion)
  • Table 86. ePharmacy - Prescription Drugs , by Region USD Billion (2022-2027)
  • Table 87. ePharmacy - Over The Counter (OTC) Drugs , by Region USD Billion (2022-2027)
  • Table 88. South America ePharmacy -, by Country USD Billion (2022-2027)
  • Table 89. South America ePharmacy -, by Type USD Billion (2022-2027)
  • Table 90. South America ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 91. Brazil ePharmacy -, by Type USD Billion (2022-2027)
  • Table 92. Brazil ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 93. Argentina ePharmacy -, by Type USD Billion (2022-2027)
  • Table 94. Argentina ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 95. Rest of South America ePharmacy -, by Type USD Billion (2022-2027)
  • Table 96. Rest of South America ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 97. Asia Pacific ePharmacy -, by Country USD Billion (2022-2027)
  • Table 98. Asia Pacific ePharmacy -, by Type USD Billion (2022-2027)
  • Table 99. Asia Pacific ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 100. China ePharmacy -, by Type USD Billion (2022-2027)
  • Table 101. China ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 102. Japan ePharmacy -, by Type USD Billion (2022-2027)
  • Table 103. Japan ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 104. India ePharmacy -, by Type USD Billion (2022-2027)
  • Table 105. India ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 106. South Korea ePharmacy -, by Type USD Billion (2022-2027)
  • Table 107. South Korea ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 108. Taiwan ePharmacy -, by Type USD Billion (2022-2027)
  • Table 109. Taiwan ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 110. Australia ePharmacy -, by Type USD Billion (2022-2027)
  • Table 111. Australia ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 112. Rest of Asia-Pacific ePharmacy -, by Type USD Billion (2022-2027)
  • Table 113. Rest of Asia-Pacific ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 114. Europe ePharmacy -, by Country USD Billion (2022-2027)
  • Table 115. Europe ePharmacy -, by Type USD Billion (2022-2027)
  • Table 116. Europe ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 117. Germany ePharmacy -, by Type USD Billion (2022-2027)
  • Table 118. Germany ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 119. France ePharmacy -, by Type USD Billion (2022-2027)
  • Table 120. France ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 121. Italy ePharmacy -, by Type USD Billion (2022-2027)
  • Table 122. Italy ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 123. United Kingdom ePharmacy -, by Type USD Billion (2022-2027)
  • Table 124. United Kingdom ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 125. Netherlands ePharmacy -, by Type USD Billion (2022-2027)
  • Table 126. Netherlands ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 127. Rest of Europe ePharmacy -, by Type USD Billion (2022-2027)
  • Table 128. Rest of Europe ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 129. MEA ePharmacy -, by Country USD Billion (2022-2027)
  • Table 130. MEA ePharmacy -, by Type USD Billion (2022-2027)
  • Table 131. MEA ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 132. Middle East ePharmacy -, by Type USD Billion (2022-2027)
  • Table 133. Middle East ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 134. Africa ePharmacy -, by Type USD Billion (2022-2027)
  • Table 135. Africa ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 136. North America ePharmacy -, by Country USD Billion (2022-2027)
  • Table 137. North America ePharmacy -, by Type USD Billion (2022-2027)
  • Table 138. North America ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 139. United States ePharmacy -, by Type USD Billion (2022-2027)
  • Table 140. United States ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 141. Canada ePharmacy -, by Type USD Billion (2022-2027)
  • Table 142. Canada ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 143. Mexico ePharmacy -, by Type USD Billion (2022-2027)
  • Table 144. Mexico ePharmacy -, by Drug Type USD Billion (2022-2027)
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global ePharmacy -: by Type USD Billion (2016-2021)
  • Figure 5. Global ePharmacy -: by Drug Type USD Billion (2016-2021)
  • Figure 6. South America ePharmacy - Share (%), by Country
  • Figure 7. Asia Pacific ePharmacy - Share (%), by Country
  • Figure 8. Europe ePharmacy - Share (%), by Country
  • Figure 9. MEA ePharmacy - Share (%), by Country
  • Figure 10. North America ePharmacy - Share (%), by Country
  • Figure 11. Global ePharmacy - share by Players 2021 (%)
  • Figure 12. Global ePharmacy - share by Players (Top 3) 2021(%)
  • Figure 13. Global ePharmacy - share by Players (Top 5) 2021(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. The Kroger Co. (United States) Revenue, Net Income and Gross profit
  • Figure 16. The Kroger Co. (United States) Revenue: by Geography 2021
  • Figure 17. Walgreen Co. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Walgreen Co. (United States) Revenue: by Geography 2021
  • Figure 19. Walmart Stores, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Walmart Stores, Inc. (United States) Revenue: by Geography 2021
  • Figure 21. CVS Health (United States) Revenue, Net Income and Gross profit
  • Figure 22. CVS Health (United States) Revenue: by Geography 2021
  • Figure 23. Express Scripts Holding Company (United States) Revenue, Net Income and Gross profit
  • Figure 24. Express Scripts Holding Company (United States) Revenue: by Geography 2021
  • Figure 25. Giant Eagle, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Giant Eagle, Inc. (United States) Revenue: by Geography 2021
  • Figure 27. DocMorris (Zur Rose Group) (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. DocMorris (Zur Rose Group) (Switzerland) Revenue: by Geography 2021
  • Figure 29. Rowlands Pharmacy (United States) Revenue, Net Income and Gross profit
  • Figure 30. Rowlands Pharmacy (United States) Revenue: by Geography 2021
  • Figure 31. OptumRx Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. OptumRx Inc. (United States) Revenue: by Geography 2021
  • Figure 33. MediSave (United States) Revenue, Net Income and Gross profit
  • Figure 34. MediSave (United States) Revenue: by Geography 2021
  • Figure 35. Global ePharmacy -: by Type USD Billion (2022-2027)
  • Figure 36. Global ePharmacy -: by Drug Type USD Billion (2022-2027)
  • Figure 37. South America ePharmacy - Share (%), by Country
  • Figure 38. Asia Pacific ePharmacy - Share (%), by Country
  • Figure 39. Europe ePharmacy - Share (%), by Country
  • Figure 40. MEA ePharmacy - Share (%), by Country
  • Figure 41. North America ePharmacy - Share (%), by Country
List of companies from research coverage that are profiled in the study
  • The Kroger Co. (United States)
  • Walgreen Co. (United States)
  • Walmart Stores, Inc. (United States)
  • CVS Health (United States)
  • Express Scripts Holding Company (United States)
  • Giant Eagle, Inc. (United States)
  • DocMorris (Zur Rose Group) (Switzerland)
  • Rowlands Pharmacy (United States)
  • OptumRx Inc. (United States)
  • MediSave (United States)
Additional players considered in the study are as follows:
eDrugstore.MD (United States) , The SANICARE Group (Sweden) , CanDrugstore.com (Canada) , Domzdrowia.pl SA (Poland) , CanadaDrugs.com (Canada)
Select User Access Type

Key Highlights of Report


Mar 2022 208 Pages 91 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global ePharmacy - Market Quantitative research analysis
Global ePharmacy - Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The ePharmacy - study can be customized to meet your requirements. The market size breakdown by type [Skin Care, Dental, Cold and Flu, Vitamins, Weight Loss and Others], by end use application [].
The ePharmacy - Market is gaining popularity and expected to see strong valuation by 2027.
According to AMA, the Global ePharmacy - market is expected to see growth rate of 15.8%.

Know More About Global ePharmacy - Market Report?

Have a Query? Click Here

Other Related Reports

Capillary Blood Collection Tubes Comprehensive Study by Type (Plastic Blood Collection Tubes, Glass Blood Collection Tubes, Stainless Steel Blood Collection Tubes, Ceramic Blood Collection Tubes), Ap...
$ 3800
Porcine Vaccines Comprehensive Study by Type (Inactivated vaccines, Live attenuated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, DNA vaccines), Application (Swine Fever Vaccin...
$ 3450
Endocrinology Drugs Comprehensive Study by Type (Diabetic Aagents, Hormone Agonists, Hormone Antagonists), Drug (Prescription Drugs, Over-the-counter Drugs), End User (Hospitals, Commercial Laborator...
$ 3350
Cancer Supportive Care Products Comprehensive Study by Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Leukemia, Ovary Cancer, Melanoma Cancer, Others), Distrib...
$ 3750
Bulk Drug Comprehensive Study by Type (Branded Prescription Drugs, Over-The-Counter Drugs, Generic Prescription Drugs), Application (Pharmaceutical, Healthcare), Processing Stages (Primary Processing...
$ 3750
Hemorrhagic Septicemia Vaccines Comprehensive Study by Type (Oil - Adjuvant, Aluminium Hydroxide- Adjuvant), Application (Cattle, Buffaloes), End User (Veterinary Hospitals, Veterinary Clinics, Anima...
$ 3500